Research and Markets has announced the addition of the "Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016" report to their offering.
Peripheral T-Cell Lymphomas (PTCL) pipeline therapeutics constitutes close to 31 molecules
Out of which approximately 31 molecules are developed by Companies. Our latest report Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Peripheral T-Cell Lymphomas (PTCL), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Peripheral T-Cell Lymphomas (PTCL) Peripheral T-cell lymphoma (PTCL) is a rare and often aggressive (fast-growing) cancer that develops from white blood cells called T-lymphocytes, or T-cells. T-cells are an important part of the immune system; they help the body to fight infection. In cases when these cells start to grow too quickly and resist dying, they can accumulate in the body. Symptoms may include fatigue, a painless swelling in the neck, armpit or groin (due to an enlarged lymph node), night sweats and rash. The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 19, 5, 4 and 1 respectively.
Furthermore, this report also reviews of key players involved in therapeutic development for Peripheral T-Cell Lymphomas (PTCL) and features dormant and discontinued projects.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/ql4qhn/peripheral_tcell.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161012005860/en/Business Wire
Last updated on: 12/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.